Perioperative management of lithium in the patient undergoing pituitary surgery: a case report.
Affiliation
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation TrustPublication date
2022-05-08Subject
NeurologySurgery
Patients. Primary care. Medical profession. Forensic medicine
Ear, Nose & Throat
Metadata
Show full item recordAbstract
Lithium is a psychotropic drug used primarily in the treatment of bipolar disorder. It is renally excreted and characteristically causes nephrogenic diabetes insipidus as an adverse drug reaction. Lithium also requires serum level monitoring as there is a narrow therapeutic window and untreated toxicity can result in neurological sequelae including drowsiness, coma, seizures, and ultimately death. We present the case of a 65-year old man admitted for pituitary surgery complicated by post-operative difficult fluid management and subsequent lithium toxicity. We highlight this rare situation and the need to be vigilant in the peri-operative period with any patients on lithium who undergo pituitary surgery.Citation
Richards E, Pankhania M, Thomas C, Jolly K, Ayuk J, Ahmed S. Perioperative management of lithium in the patient undergoing pituitary surgery: a case report. Br J Neurosurg. 2024 Aug;38(4):1042-1044. doi: 10.1080/02688697.2021.2010651. Epub 2022 May 8.Type
ArticleAdditional Links
https://www.tandfonline.com/journals/ibjn20PMID
35531871Journal
British Journal of NeurosurgeryPublisher
Taylor & Francisae974a485f413a2113503eed53cd6c53
10.1080/02688697.2021.2010651